ADC Therapeutics SA Common Shares (ADCT) - Live Price

ADC Therapeutics SA Common Shares

ADC Therapeutics SA Common Shares, commonly referred to as ADCT, are publicly traded shares on various stock exchanges, including the Nasdaq Global Market. The company, ADC Therapeutics, is a clinical-stage biopharmaceutical company focused on developing innovative cancer treatments. Its pipeline includes several drug candidates targeting various solid tumor indications. Investors interested in the biotechnology sector and innovative cancer treatments may find ADCT shares a compelling investment opportunity. As the company progresses in its clinical trials and demonstrates proof of concept, the potential for significant returns could attract more investors and contribute to overall market liquidity. However, it is essential to consider the risks associated with biotechnology stocks, including the possibility of failure for individual drug candidates and the overall volatility of the sector.

Get ADC Therapeutics SA Common Shares Price Change Alerts

Verdasi can notify you when ADCT goes up or down. Get a text message or email when ADC Therapeutics SA Common Shares changes in price.

How are ADC Therapeutics SA Common Shares divided?

Mutual Funds actively invest in , controlling roughly 20.32% of all ADC Therapeutics SA Common Shares.

• Individual Stakeholders: 0.00%
• Mutual Fund: 20.32%
• Other Institutions: 0.00%

How much is ADC Therapeutics SA Common Shares stock worth?

ADC Therapeutics SA Common Shares (ADCT) is worth $1.92 USD as of December 20, 2024, 11:15 pm UTC time.
View the interactive graph to see how much ADC Therapeutics SA Common Shares has changed in the last hour or historically.